Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2020 Aug 8;99:226–228. doi: 10.1016/j.ijid.2020.08.003

SARS-CoV-2-related mortality in a rural Latin American population

Oscar H Del Brutto a,, Aldo F Costa b, Robertino M Mera c, Bettsy Y Recalde b, Javier A Bustos d, Héctor H García d
PMCID: PMC7414723  PMID: 32781165

Highlights

  • There is no evidence on mortality rates of SARS-CoV-2 in remote rural settings.

  • We calculated SARS-CoV-2 mortality rate of adults living in Atahualpa (rural Ecuador).

  • SARS-CoV-2 mortality rate was 15.7/1,000, which increased to 68.9/1,000 when only older adults were considered.

  • Most deaths occurred over a two-month period, and markedly decreased subsequently.

Keywords: SARS-CoV-2, Coronavirus-19, Mortality, Rural setting, Ecuador

Abstract

A sudden increase in adult mortality associated with respiratory diseases was noticed in Atahualpa (a rural Ecuadorian village), coinciding with the introduction of SARS-CoV-2 in the region. From a total of 1,852 individuals aged ≥18 years, 40 deaths occurred between January and June, 2020. In addition, a seroprevalence survey showed that 45% of the adult population have SARS-CoV-2 antibodies. Verbal autopsies revealed SARS-CoV-2 as the most likely cause of death in 29 cases. The mean age of suspected or confirmed SARS-CoV-2 cases was 76.9 ± 12.1 years, while that of those dying from unrelated causes was 60.3 ± 20.4 years (p = 0.003). The overall mortality rate was 21.6 per 1,000 population (95% C.I.: 15.9 – 29.2), almost three-quarters of it due to SARS-CoV-2 (15.7 per 1,000; 95% C.I.: 11 – 22.4). This configures a 266% of excess mortality when compared to 5.9 per 1,000 (95% C.I.: 3.3 – 10.6) deaths from other causes. When SARS-CoV-2 mortality rate was calculated in individuals aged ≥60 years, it raised up to 68.9 per 1,000 (95% C.I.: 47.8 – 98.4). After peaking in April and May, mortality significantly decreased. It is possible that the high proportion of infected individuals and the resulting herd immunity contributed to the observed reduction in mortality.

Introduction

The novel Coronavirus Disease 2019 pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has claimed the lives of more than 600 thousand people (Anon., 2020). Highly prevalent in urban centers of China, USA, and European countries, the disease has spread to Africa and Latin America, where rural populations are especially vulnerable because of multiple factors inherent to under-development (Zhao et al., 2020, Caicedo-Ochoa et al., 2020, Miller et al., 2020). Despite the vast information on SARS-CoV-2 published from urban centers, there is little or nil evidence about the mortality rate of individuals with SARS-CoV-2 in remote rural settings.

A sudden increase in adult mortality associated with respiratory diseases was noticed in Atahualpa, a rural Ecuadorian village (2º18’S, 80º46’W), coinciding with the introduction of SARS-CoV-2 in the region (Hallo et al., 2020). Such deaths started on March 2020, reached a peak on April and May, and subsequently declined during June. Here, we report SARS-CoV-2 mortality rates in Atahualpa residents aged ≥18 years.

Methods

Departing from the archives of the Atahualpa Project, we obtained data from our last census of the adult population, registered deaths occurring during the first semester of 2020, and reported the results of a door-to-door seroprevalence survey conducted during May, 2020 (Del Brutto et al., 2020). Deaths were classified in SARS-CoV-2-related and unrelated (based on verbal autopsies and confirmatory tests). Verbal autopsies findings were categorized according to World Health Organization operational definitions for suspected COVID-19 case, as follows: 1) acute febrile respiratory illness and exposure of community transmission to COVID-19 disease during the 14 days prior to symptom onset; 2) any acute respiratory illness and contact with a confirmed or probable COVID-19 case in the last 14 days; and 3) severe acute respiratory illness (fever and at least one sign/symptom of respiratory disease and requiring hospitalization) in the absence of an alternative diagnosis (World Health Organization, 2020). Mortality rates for the entire cohort and for the subset of older adults (aged ≥60 years) were calculated.

Results

A door-to-door survey of Atahualpa residents (December, 2019), conducted as part of the Atahualpa Project cohort study (Del Brutto et al., 2018), revealed 1,852 individuals aged ≥18 years, 392 of whom were aged ≥60 years. Forty deaths occurred between January and June, 2020. Verbal autopsies – provided by family related households members – revealed SARS-CoV-2 as the most likely cause of death in 29 cases (World Health Organization, 2020), including five confirmed SARS-CoV-2 deaths (where the individuals had diagnostic tests performed at a local hospital). All the 24 individuals who died with suspected COVID-19 disease had fever and respiratory symptoms and entered into WHO Category 2, including 19 who had seropositive household members and five reporting frequent contact with seropositive neighbors.

Other causes of death (cancer, chronic liver failure, head trauma and suicide) occurred in the remaining 11 cases. In January and February there were four deaths, all unrelated to SARS-CoV-2. In March, two of four deaths were from suspected SARS-CoV-2 infection. In April there were 22 deaths, 18 of which were related to suspected or confirmed SARS-CoV-2 infections, as were seven out of eight deaths in May. The two deaths in June were confirmed SARS-CoV-2 cases.

The mean age of the 29 suspected or confirmed SARS-CoV-2 cases was 76.9 ± 12.1 years, while that of those dying from unrelated causes was 60.3 ± 20.4 years (p  = 0.003). Twenty-seven out of the 29 deaths likely related to SARS-CoV-2 were individuals aged ≥60 years, as were seven out of 11 deaths from unrelated causes (p  = 0.039).

The overall mortality rate in Atahualpa residents aged ≥18 years was 21.6 per 1,000 population (95% C.I.: 15.9 – 29.2), almost three-quarters of it due to SARS-CoV-2 (15.7 per 1,000; 95% C.I.: 11 – 22.4). This configures a 266% of excess mortality when compared to 5.9 per 1,000 (95% C.I.: 3.3 – 10.6) deaths from other causes. When SARS-CoV-2 mortality rate was calculated in the subset of individuals aged ≥60 years, it raised up to 68.9 per 1,000 (95% C.I.: 47.8 – 98.4).

Discusion

In Atahualpa, SARS-CoV-2 rapidly spread across the village, markedly increasing mortality during April and May, 2020 (Figure 1 ), and infecting 45% of the adult population, in just a few months (Del Brutto et al., 2020). During a four-month period, 1.6% of the entire adult population of Atahualpa, including 6.9% (27/392) of older adults, died from SARS-Cov-2-related causes. After peaking in April and May, however, mortality significantly decreased. Since preventive measures are poorly endorsed by locals, the high proportion of infected individuals and the resulting herd immunity may have contributed to the observed reduction in mortality (Britton et al., 2020).

Figure 1.

Figure 1

Mortality in individuals aged 18 years or more in Atahualpa from January to June, 2020, considering total deaths, as well as those related to SARS-CoV-2, and to unrelated causes.

Atahualpa’s mortality scenario is typical of closed populations where inhabitants are immunologically naïve to a rapidly spreading pathogen. To the immunological naivety of these populations, it must be added the adverse circumstances in which they live regarding inadequacy of control measures, poor social determinants of health and inadequate access to medical care. Rural communities of Latin America are not prepared for this pandemic (Miller et al., 2020, Amigo, 2020). Further studies in rural populations are needed to get more insights on the pattern of mortality of individuals with SARS-CoV-2 living in remote settings.

Funding source

Study supported by Universidad Espíritu Santo – Ecuador. The sponsor had no role in the design of the study, nor in data collection or analyses, or in the decision to submit this work for publication.

Ethical approval

The Independent Review Board of Universidad Espiritu Santo (IORG: 0010320; FWA: 00028878) approved the study.

Conflicts of interest

The authors declare that they don’t have any conflict of interest to disclose.

References

  1. Amigo I. Indigenous communities in Brazil fear pandemic’s impact. Science. 2020;368(6489):352. doi: 10.1126/science.368.6489.352. [DOI] [PubMed] [Google Scholar]
  2. Anon . 2020. COVID-19 Coronavirus Pandemic.https://www.worldometers.info/coronavirus/ Accessed on July 23, 2020. [Google Scholar]
  3. Britton T., Ball F., Trapman P. A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2. Science. 2020 doi: 10.1126/science.abc6810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Caicedo-Ochoa Y., Rebellón-Sánchez D.E., Peñaloza-Rallón M., Cortés-Motta H.F., Méndez-Fandiño Y.R. Effective reproductive number estimation for initial stage of COVID-19 pandemic in Latin American countries. Int J Infect Dis. 2020;95:316–318. doi: 10.1016/j.ijid.2020.04.069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Del Brutto O.H., Mera R.M., Castillo P.R., Del Brutto V.J. Key findings from the Atahualpa Project: what should we learn? Expert Rev Neurother. 2018;18(1):5–8. doi: 10.1080/14737175.2018.1400382. [DOI] [PubMed] [Google Scholar]
  6. Del Brutto O.H., Costa A.F., Mera R.M., Recalde B.Y., Bustos J.A., García H.H. SARS-CoV-2 in rural Latin America. A population-based study in coastal Ecuador. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hallo A., Rojas A., Hallo C. Perspective from Ecuador, the second country with more confirmed cases of coronavirus disease 2019 in South America: a review. Cureus. 2020;12:e7452. doi: 10.7759/cureus.7452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Miller M.J., Loaiza J.R., Takyar A., Gilman R.H. COVID-19 in Latin America: novel transmission dynamics for a global pandemic? PloS Negl Trop Dis. 2020;14 doi: 10.1371/journal.pntd.0008265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. World Health Organization . 2020. Global surveillance for COVID-19 caused by human infection with COVID-19 virus.https://apps.who.int/iris/bitstream/handle/10665/331506/WHO-2019-nCoV-SurveillanceGuidance-2020.6-eng.pdf?sequence=1&isAllowed=y Accessed on July 2, 2020. [Google Scholar]
  10. Zhao Z., Li X., Liu F., Zhu C., Ma C., Wang L. Prediction of the COVID-19 spread in African countries and implications for prevention and control: a case study in South Africa, Egypt, Algeria, Nigeria, Senegal and Kenia. Sci Total Environ. 2020;729 doi: 10.1016/j.scitotenv.2020.138959. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Infectious Diseases are provided here courtesy of Elsevier

RESOURCES